InflammaD - EyeD Pharma
Alternative Names: InflammaD; InflammaD implantLatest Information Update: 20 May 2024
At a glance
- Originator EyeD Pharma
- Class Eye disorder therapies
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Research Eye disorders